Order Article Reprints

Davis SL, Messersmith WA, Purcell WT, Lam ET, Corr BR, Leal AD, Lieu CH, O’Bryant CL, Smoots SG, Dus ED, et al. A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers. 2024; 16(8):1456. https://doi.org/10.3390/cancers16081456

Davis, S. Lindsey, Wells A. Messersmith, W. Thomas Purcell, Elaine T. Lam, Bradley R. Corr, Alexis D. Leal, Christopher H. Lieu, Cindy L. O’Bryant, Stephen G. Smoots, Evan D. Dus, and et al. 2024. "A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors" Cancers 16, no. 8: 1456. https://doi.org/10.3390/cancers16081456

Davis, S. L., Messersmith, W. A., Purcell, W. T., Lam, E. T., Corr, B. R., Leal, A. D., Lieu, C. H., O’Bryant, C. L., Smoots, S. G., Dus, E. D., Jordan, K. R., Serkova, N. J., Pitts, T. M., & Diamond, J. R. (2024). A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers, 16(8), 1456. https://doi.org/10.3390/cancers16081456